metformin has been researched along with Hyperlipoproteinemia in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 12-week double-blind placebo-controlled trial to study the effects of metformin on lipoprotein concentration and composition was performed in forty patients with NIDDM and hyperlipoproteinemia." | 5.07 | Effects of metformin on dyslipoproteinemia in non-insulin-dependent diabetes mellitus. ( Schneider, J, 1991) |
| "Forty patients with NIDDM and hyperlipoproteinemia were selected for a 12-week double-blind placebo-controlled trial to study the effects of metformin on lipoprotein concentration and composition." | 5.06 | Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus. ( Erren, T; Kaffarnik, H; Schneider, J; Zöfel, P, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, J | 2 |
| Erren, T | 1 |
| Zöfel, P | 1 |
| Kaffarnik, H | 1 |
2 trials available for metformin and Hyperlipoproteinemia
| Article | Year |
|---|---|
Effects of metformin on dyslipoproteinemia in non-insulin-dependent diabetes mellitus.
Topics: Aged; Apoproteins; Arteriosclerosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; | 1991 |
Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Apoproteins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipop | 1990 |